Dose remote preconditioning by aortic constriction (RPAC) affords cardioprotection similar to classical or other remote ischemic preconditioning stimulus? Moreover study was also designed to investigate role of inducible nitric oxide synthase in remote preconditioning by aortic constriction. There are sufficient evidences that "ischemic preconditioning" has surgical applications and afford clinically relevant cardioprotection. Transient occlusion of circumflex artery, renal artery, limb artery or mesenteric artery preconditions the myocardium against ischemia reperfusion injury in case of ischemic heart disease leading to myocardial infraction. 
Introduction
Myocardial Infract size is an established determinant of clinical complications and patient survival in an event of acute coronary occlusion. Ischemic heart disease leading to myocardial infarction is considered to be one of the major causes of cardiovascular morbidity and mortality.
Revascularization of ischemic heart with thrombolytic agents, angioplasty or saphenous vein grafting is primary requirement. Moreover, a delay to institute reperfusion deprives most of its beneficial effects as a direct function of time. Thus attention has been focused to understand the adaptive mechanisms that will make the myocardium more resistant to ischemia of longer duration and to restore its viability on reperfusion. Repeated short episodes of ischemiareperfusion have been demonstrated to make the myocardium transiently more resistant to the deleterious effects of subsequent and prolonged ischemic insult. This paradoxical form of myocardial adaptation has been termed as ischemic preconditioning which was reported to provide protection against infract size and arrhythmias and improving post ischemic contractile function. Thus ischemic preconditioning has surgical application and affords clinically relevant cardio protection. Preconditioning has been reported to protect the myocardium even in diseased states such as hypertrophy and diabetic myocardium [1] [2] [3] .
Ischemic preconditioning is acquired by transient ischemic stress in the same tissue or organ 4 .
aminoguaidine and S-methyl-isothiourea, when administered before sustained ischemia abolish the preconditioning -induced delayed cardioprotection against stunning 8 and infraction 16, 17 .
Moreover administration of endotoxin and nontoxic derivative MLA confers preconditioning like delayed cardioprotective through iNOS induction 18, 19 . Role of inducible nitric oxide synthase by intestinal ischaemia induce late preconditioning against myocardial infarction 20 .
The present study is designed to investigate the acute and delayed cardioprotective effect of remote aortic preconditioning. Moreover, it is also envisaged to study the role of inducible nitric oxide synthase (iNOS) in cardioprotective effect of remote preconditioning by aortic constriction.
Materials and methods:

Animals
Wistar albino rats (100-300 g) of either sex were employed in the present study. They are fed on standard laboratory chow (Kisan Feeds Ltd., New Delhi, India) and had free access to tap water ad libitum. All the experimental protocols were performed according to Animals Ethical Committee, Gyan Vihar School of Pharmacy, and Protocol No. 42.
Remote aortic preconditioning
Rats were anesthetized with thiopental sodium (25 mg Kg -1 i.v.). A 2 cm long incision was given on the abdomen. Lower portion of abdominal aorta was isolated and the suture (numbered 5/0) was passed beneath it away from the origin of renal arteries. Aorta was occluded by tying a shoe lace knot and knot was untied from reperfusion. Aorta was occluded for 5 min and was reperfused for 5 min. Four such episodes were used to produce preconditioning 21 . In case animals were to be used after 24h of aortic preconditioning the abdomen was sutured in layers and animals were allowed to recover.
Global ischemia and reperfusion in isolated rat heart
Heparin (500IU, i.p.) was administered about 20 min. before sacrificing the animal. Heart was rapidly excised and immediately mounted on Langendorff's apparatus 22 
Estimation of Lactate dehydrogenase (LDH)
LDH was estimated in coronary effluent by 2,4-DNPH method 23 .
Group XXI (SWOP S-methyl isothiourea (3mg/kg i.v.) Treated Control Group; n=6)
Rats were subjected to same protocol as described in group XIII except that S-methyl isothiourea (3mg/kg i.v.) was administered 10 min before excising the heart for Langendorff's perfusion.
Group XXII (SWOP S-methyl isothiourea (3mg/kg i.v.) Treated Remote Preconditioning
by Aortic Constriction Group; n=6)
Rats were subjected to same protocol as described in-group XIV except that S-methyl isothiourea (3mg/kg i.v.) was administered 10 min before excising the heart for Langendorff's perfusion.
Group XXIII (SWOP 1400W (1mg/kg i.v.) Treated Control Group; n=6)
Rats were subjected to same protocol as described in group XIII except that 1400W (1mg/kg i.v.)
was administered 10 min before excising the heart for Langendorff's perfusion.
Group XXIV (SWOP 1400W (1mg/kg i.v.) Treated Remote Preconditioning by Aortic
Constriction Group; n=6)
Rats were subjected to same protocol as described in-group XIV except that 1400W (1mg/kg i.v.) was administered 10 min before excising the heart for Langendorff's perfusion.
Drugs and chemicals
Aminoguanidine hydrogen carbonate (Lancaster Chemicals, Madras, India), 1400W ([N- (3- (aminomethyl)benzyl)acetamidine]sulfate) (a specific iNOS inhibitor) was from Acros Organics (Noisy le Grand, France), dissolved in distilled water immediately before use, S-methylthiourea sulfate (Sigma-Aldrich USA) L-NAME (nitro-L-arginine-methylester) (non-specific iNOS inhibitor) (Sigma-Aldrich USA), Tris buffer was prepared by adding 50 ml of 0.2 M Tris (CDH chemicals, N.Delhi, India) in 32.5 ml of 0.2 M HCl and volume was made up to 200 ml with distilled water. All other reagents used in the study were analar grade of Qualigens (Glaxo, Mumbai, India)
Statistical analysis
Values for enzymatic data and infract-size were expressed as mean ± S.E.M. Statistical significance was calculated using one way analysis of variance. Dunnett's test and student t test were employed as post-hoc tests for comparison with control group and for multiple comparisons between groups respectively. A value of p < 0.05 is considered to be statistically significant.
Sigma10 software was used for statistical analysis. pretreatment and remote aortic preconditioning produced no significant change in flow rate
Results
Effect
[ Table 1 ] and heart rate [ Table 2 ].
Effect of NOS (Nitric Oxide Synthase) Inhibitors pretreatment on ischemia/reperfusioninduced myocardial injury
The peak increase in release of LDH in coronary effluent of isolated rat heart subjected to global ischaemia and reperfusion was noted immediately and 30 min after reperfusion [ produced acute (FWOP) and delayed (SWOP) cardioprotective effect.
Effect of NOS (Nitric Oxide Synthase) Inhibitors on Acute (FWOP) and Delayed (SWOP) remote preconditioning by aortic constriction (RPAC) in ischemia/reperfusion-induced myocardial injury
In rat heart isolated immediately after remote preconditioning by aortic constriction (Acute/FWOP) and pretreatment with Aminoguanidine(150 mg/Kg s.c.), Aminoguanidine (300 mg/Kg s.c.), S-methyl isothiourea (3 mg/Kg i.v.), 1400W (1 mg/Kg i.v.) produced no significant effect on preconditioning induced decrease in LDH [ Table 3 ], CK [ Table 5 ] release and myocardial infract size [ Table 7 ]. L-NAME (10 mg/Kg i.v.) administration increase release of LDH [ Table 3 ] CK [ Table 3 ] in coronary effluent and also increased myocardial infract size
[ Table 5 ] in Acute/FWOP remote preconditioning by aortic constriction.
On the other hand, administration of L-NAME(10 mg/Kg i.v.), Aminoguanidine(150 mg/Kg s.c.), Aminoguanidine (300 mg/Kg s.c.), S-methyl isothiourea (3 mg/Kg i.v.), 1400W (1 mg/Kg i.v.) 24 hr after subjecting rat heart to remote aortic preconditioning (delayed/SWOP), attenuated remote preconditioning by aortic constriction (RPAC) induced decrease in LDH [ Table 4 ], CK
[ Table 6 ] release in coronary effluent and myocardial infract size [ Table 8 ].
Discussion
In the present study, four episodes of occlusion of aorta followed by reperfusion markedly protected the rat heart against sustained ischemia and reperfusion induced myocardial injury. The . In the present study the delayed cardio protective effect of remote by aortic constriction is attenuated with aminoguanidine, L-NAME,
S-methyl isothiourea and 1400W (NOS inhibitors). Aminoguanidine is reported to attenuate
endotoxin-induced delayed cardio protection 19 .
1400W, a selective iNOS inhibitor, was used to determine whether this isozyme was involved in the cardio-protective mechanism. 1400W was chosen because, because of its higher selectivity for iNOS (5000 times more selective for iNOS than for eNOS) 25 . A specific role of iNOSderived NO as a mediator of delayed cardioprotection has also been reported for ischaemic preconditioning (IP). Thus, iNOS induction shown to be necessary for the development of delayed protection conferred by IP in anaesthetised rabbit models of myocardial infarction and stunning 25 Recent evidence has shown that the cardioprotection afforded by the late phase of ischemic preconditioning (PC) is mediated by upregulation of inducible nitric oxide synthase (iNOS).
However, the specific cardiac cell type(s) that express(es) iNOS in response to ischemic PC remains unknown. Thus, mice underwent a sequence of six cycles of 4-min coronary occlusion/4-min reperfusion, which induces late PC, and tissue samples were collected at serial times for measurement of mRNA (Northern) and protein levels (Western). In addition, whole heart samples were cryosectioned for in situ hybridization and immunohistochemistry. The steady-state levels of iNOS mRNA in the ischemic regions started to increase at 1 h after ischemic PC, peaked at 3 h (201±31% of sham, n=5 P<0.01) and remained elevated at 24 h (177±22% of sham, n=5 P<0.01). In accordance with these data, iNOS protein expression was increased at 24 h (219±41% of sham, n=5 P<0.01). In contrast, neither endothelial nitric oxide synthase (eNOS) mRNA levels nor its protein expression changed at any time-point 26 .
Administration of aminoguanidine (300 mg/ kg, s.c.) or S-methylisothiourea sulfate (3 mg/ kg, i.v.), both relative inducible NO synthase inhibitors, 60 or 30 min before sustained myocardial ischemia not only abolished the late preconditioning afforded by intestinal ischemia, but also inhibited the ability of intestinal ischemia preconditioning to significantly reduce neutrophil infiltration. A change in inducible NO synthase activity was not observed in normal myocardium 24 h after intestinal ischemia, but 30 min of coronary occlusion significantly increased the inducible NO synthase activity in the preconditioned group, which was abolished by aminoguanidine or S-methylisothiourea sulfate. In conclusion, above data provide pharmacological evidence that induction of inducible nitric oxide synthase, following intestinal ischemia, is associated with increased myocardial tolerance to infarction 24 h later 20 . The same is confirmed in the present study that aminoguanidine (300 mg/ kg, s.c.) or S-methylisothiourea sulfate (3 mg/ kg, i.v.), both relative inducible NO synthase inhibitors, abolished the late preconditioning afforded by remote preconditioning by aortic constriction.
Aminoguanidine in the dose employed is reported to inhibit selectively iNOS 27, 28 . The late phase of ischemic preconditioning is a delayed adaptive response that renders the heart relatively resistant to sustained ischemia and reperfusion. NO is identified as a initial signal for triggering the late cardio protective effect of classical ischemic preconditioning 15, 16, 29 . Activation of proinflammatory mediators such as cytokines and inducible nitric oxide synthase (iNOS) have been
shown to contribute to myocardial injury after ischemia and reperfusion [30] [31] [32] . Up regulation of iNOS may account to precondition the heart by brief ischemic stress. Different induction of mRNA for inducible nitric oxide synthase in rat smooth muscle cells in culture and in aortic strips has been found. One of the transcription factors that could activate gene expression in response to ischemic preconditioning is the nuclear factor κβ (NF-κβ). This oxidant sensitive transcription factor plays a critical role in the immediate -early activation of multitude of genes encoding signaling and defense proteins expressed in the response to various stressful situations and therefore appears to be a general mediator of cellular responses to stress [33] [34] [35] . It is well established that the 5' flanking region of iNOS gene contains a consenus sequence that NF-κβ and that the activation of NF-κβ is a central mechanism controlling the induction of iNOS in several cell types including cardiac myocytes 31, [36] [37] [38] . Therefore, it may be possible that the noted delayed cardio protective effect remote preconditioning by aortic constriction may be due to upregulation of iNOS due to shear stress exerted on myocardium by aortic occlusions. This contention is supported by the results of the present study because aminoguanidine, a selective iNOS inhibitor, attenuated the delayed cardio protective effect of remote aortic preconditioning 27, 28 . Our results are supported by observations, which implicate the role of iNOS in delayed cardio protective effect of classical ischemic preconditioning 15, 16, 19 . It is further supported that pacing induced delayed protection against arrythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase 39 . Delayed or Second window preconditioning induced by adenosine A1 receptor activation is independent of early generation of nitric oxide or late induction of inducible nitric oxide synthase 40 .
Induction of iNOS requires a lag phase. Acute cardio protective effect of remote preconditioning by aortic constriction was observed immediately after the preconditioning stimulus. Therefore the involvement of iNOS in it, may be remote because induction of iNOS require some lag time 26, 27 . Moreover, this contention is further supported by our results which have demonstrated that aminoguanidine, S-methyl isothiourea, 1400W in the dosage employed has produced no notable effect on acute cardio-protective effect of remote preconditioning afforded by aortic constriction. Therefore, it may be possible that the acute cardio-protective effect of remote preconditioning by aortic constriction may be mediated through the activation of eNOS may be as result of shear stress 32, 41 and confirmed by present study because L-NAME, a non-specific NOS inhibitor abolished acute cardioprotective effect produced by remote preconditioning by aortic constriction.
Over the past decade, an enormous number of studies (>100) have focused on the role of nitric oxide (NO) in myocardial ischemia. It is important to distinguish the function of NO in unstressed (non-preconditioned) myocardium from its function in preconditioned myocardium (i.e. myocardium that has shifted to a defensive phenotype in response to stress). The time has come to translate this enormous body of experimental evidence into clinically useful therapies by harnessing the cytoprotective properties of NO 42-46 .
Preconditioning is in experimental studies the most powerful mode of cardio protection known.
The signal transduction pathways involve a variety of trigger substances, mediators, receptors, and effectors. The studies of preconditioning in cardiac surgery provide conflicting results but the majority of studies show that ischemic preconditioning is an effective adjunct to myocardial protection. However, ischemic preconditioning with repeated clamping of the aorta will never get widespread use. If the "preconditioning response" is to be exploited in cardiac surgery, targeting the underlying molecular mechanisms must provide easily applicable techniques or drugs, which are shown in large scale clinical studies to be beneficial 47 . Remote ischemic preconditioning increases the tolerance of the myocardium to ischemia, reduces ischemic chest discomfort during coronary balloon occlusion, and reduces the prevalence of cardiac troponin I
[cTnI] release after elective PCI 48 . The data add to the growing number of studies suggesting that remote ischemic preconditioning is a safe, effective, noninvasive, and cost-effective strategy for reducing ischemic cardiac damage in settings where myocardial ischemic damage is expected 49 .
Conclusions
On the basis of the above results and discussion, it can be concluded that remote preconditioning by aortic constriction has produced acute and delayed cardioprotective effect as found earlier with classical and other remote preconditioning stimulus. Recent evidence has shown that the cardioprotection afforded by the late phase of ischemic preconditioning (PC) is mediated by inducible nitric oxide synthase (iNOS). The steady-state levels of iNOS mRNA in the ischemic regions started to increase at 1 h after ischemic PC, peaked at 3 h and remained elevated at 24 h.
In accordance with these data, iNOS protein expression was increased at 24 h 26 . In the present study iNOS has been involved in the delayed cardio-protective effect afforded by remote preconditioning by aortic constriction as supported by above findings. On the other hand activation of iNOS may not participate in acute cardio-protective effect of remote preconditioning by aortic constriction.
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